vs
CLOVER HEALTH INVESTMENTS, CORP.（CLOV）与罗技（LOGI）财务数据对比。点击上方公司名可切换其他公司
罗技的季度营收约是CLOVER HEALTH INVESTMENTS, CORP.的1.9倍（$1.4B vs $749.2M），罗技净利率更高（17.7% vs 3.6%，领先14.0%），CLOVER HEALTH INVESTMENTS, CORP.同比增速更快（62.0% vs 6.1%），过去两年CLOVER HEALTH INVESTMENTS, CORP.的营收复合增速更高（45.0% vs 18.5%）
克利弗健康投资公司是2014年成立的美国医疗保健企业，主营联邦医疗保险优势计划保险产品，是与美国政府直接签约合作的机构。目前公司为美国11个州的联邦医疗保险参保人提供健康管理服务，并已于2021年1月8日公开上市。
罗技国际是总部位于瑞士洛桑的跨国企业，专注于计算机外设及相关软件的研发与生产，在欧洲、亚洲、大洋洲、美洲均设有分支机构，为瑞士市场指数成分股，同时在纳斯达克交易所挂牌上市。
CLOV vs LOGI — 直观对比
营收规模更大
LOGI
是对方的1.9倍
$749.2M
营收增速更快
CLOV
高出56.0%
6.1%
净利率更高
LOGI
高出14.0%
3.6%
两年增速更快
CLOV
近两年复合增速
18.5%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $749.2M | $1.4B |
| 净利润 | $27.3M | $251.0M |
| 毛利率 | — | 43.2% |
| 营业利润率 | 3.6% | 20.1% |
| 净利率 | 3.6% | 17.7% |
| 营收同比 | 62.0% | 6.1% |
| 净利润同比 | — | 25.4% |
| 每股收益（稀释后） | $0.05 | $1.69 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLOVLOGI
| Q1 26 | $749.2M | — | ||
| Q4 25 | $487.7M | $1.4B | ||
| Q3 25 | $496.6M | $1.2B | ||
| Q2 25 | $477.6M | $1.1B | ||
| Q1 25 | $462.3M | $1.0B | ||
| Q4 24 | $337.0M | $1.3B | ||
| Q3 24 | $331.0M | $1.1B | ||
| Q2 24 | $356.3M | $1.1B |
净利润CLOVLOGI
| Q1 26 | $27.3M | — | ||
| Q4 25 | $-49.3M | $251.0M | ||
| Q3 25 | $-24.4M | $170.7M | ||
| Q2 25 | $-10.6M | $146.0M | ||
| Q1 25 | $-1.3M | $144.1M | ||
| Q4 24 | $-22.1M | $200.1M | ||
| Q3 24 | $-9.2M | $145.5M | ||
| Q2 24 | $7.4M | $141.8M |
毛利率CLOVLOGI
| Q1 26 | — | — | ||
| Q4 25 | — | 43.2% | ||
| Q3 25 | — | 43.4% | ||
| Q2 25 | — | 41.7% | ||
| Q1 25 | — | 43.1% | ||
| Q4 24 | — | 42.9% | ||
| Q3 24 | 24.5% | 43.6% | ||
| Q2 24 | 30.3% | 42.8% |
营业利润率CLOVLOGI
| Q1 26 | 3.6% | — | ||
| Q4 25 | -10.1% | 20.1% | ||
| Q3 25 | -4.9% | 16.1% | ||
| Q2 25 | -2.2% | 14.1% | ||
| Q1 25 | -0.3% | 10.5% | ||
| Q4 24 | -6.4% | 17.5% | ||
| Q3 24 | -2.7% | 14.4% | ||
| Q2 24 | 2.0% | 14.1% |
净利率CLOVLOGI
| Q1 26 | 3.6% | — | ||
| Q4 25 | -10.1% | 17.7% | ||
| Q3 25 | -4.9% | 14.4% | ||
| Q2 25 | -2.2% | 12.7% | ||
| Q1 25 | -0.3% | 14.3% | ||
| Q4 24 | -6.6% | 14.9% | ||
| Q3 24 | -2.8% | 13.0% | ||
| Q2 24 | 2.1% | 13.0% |
每股收益（稀释后）CLOVLOGI
| Q1 26 | $0.05 | — | ||
| Q4 25 | — | $1.69 | ||
| Q3 25 | — | $1.15 | ||
| Q2 25 | — | $0.98 | ||
| Q1 25 | — | $0.94 | ||
| Q4 24 | — | $1.32 | ||
| Q3 24 | — | $0.95 | ||
| Q2 24 | — | $0.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $177.6M | $1.8B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $339.4M | $2.3B |
| 总资产 | $697.7M | $4.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLOVLOGI
| Q1 26 | $177.6M | — | ||
| Q4 25 | $78.3M | $1.8B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | $194.5M | $1.5B | ||
| Q3 24 | $288.0M | $1.4B | ||
| Q2 24 | $254.8M | $1.5B |
股东权益CLOVLOGI
| Q1 26 | $339.4M | — | ||
| Q4 25 | $308.7M | $2.3B | ||
| Q3 25 | $340.9M | $2.1B | ||
| Q2 25 | $344.2M | $2.2B | ||
| Q1 25 | $336.1M | $2.1B | ||
| Q4 24 | $341.1M | $2.1B | ||
| Q3 24 | $342.2M | $2.1B | ||
| Q2 24 | $324.9M | $2.2B |
总资产CLOVLOGI
| Q1 26 | $697.7M | — | ||
| Q4 25 | $541.0M | $4.1B | ||
| Q3 25 | $559.7M | $3.7B | ||
| Q2 25 | $575.0M | $3.7B | ||
| Q1 25 | $583.7M | $3.5B | ||
| Q4 24 | $580.7M | $3.7B | ||
| Q3 24 | $653.0M | $3.6B | ||
| Q2 24 | $674.2M | $3.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $480.5M |
| 自由现金流经营现金流 - 资本支出 | — | $465.6M |
| 自由现金流率自由现金流/营收 | — | 32.8% |
| 资本支出强度资本支出/营收 | — | 1.0% |
| 现金转化率经营现金流/净利润 | — | 1.91× |
| 过去12个月自由现金流最近4个季度 | — | $903.6M |
8季度趋势，按日历期对齐
经营现金流CLOVLOGI
| Q1 26 | — | — | ||
| Q4 25 | $-66.9M | $480.5M | ||
| Q3 25 | $12.1M | $228.8M | ||
| Q2 25 | $5.4M | $125.0M | ||
| Q1 25 | $-16.3M | $129.7M | ||
| Q4 24 | $34.8M | $370.9M | ||
| Q3 24 | $50.0M | $166.0M | ||
| Q2 24 | $44.8M | $176.0M |
自由现金流CLOVLOGI
| Q1 26 | — | — | ||
| Q4 25 | $-69.0M | $465.6M | ||
| Q3 25 | $11.4M | $212.3M | ||
| Q2 25 | $4.8M | $108.8M | ||
| Q1 25 | $-16.5M | $116.9M | ||
| Q4 24 | $33.3M | $356.6M | ||
| Q3 24 | $49.6M | $151.5M | ||
| Q2 24 | $44.4M | $161.4M |
自由现金流率CLOVLOGI
| Q1 26 | — | — | ||
| Q4 25 | -14.1% | 32.8% | ||
| Q3 25 | 2.3% | 17.9% | ||
| Q2 25 | 1.0% | 9.5% | ||
| Q1 25 | -3.6% | 11.6% | ||
| Q4 24 | 9.9% | 26.6% | ||
| Q3 24 | 15.0% | 13.6% | ||
| Q2 24 | 12.5% | 14.8% |
资本支出强度CLOVLOGI
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 1.0% | ||
| Q3 25 | 0.1% | 1.4% | ||
| Q2 25 | 0.1% | 1.4% | ||
| Q1 25 | 0.0% | 1.3% | ||
| Q4 24 | 0.5% | 1.1% | ||
| Q3 24 | 0.1% | 1.3% | ||
| Q2 24 | 0.1% | 1.3% |
现金转化率CLOVLOGI
| Q1 26 | — | — | ||
| Q4 25 | — | 1.91× | ||
| Q3 25 | — | 1.34× | ||
| Q2 25 | — | 0.86× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | — | 1.85× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | 6.04× | 1.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLOV
暂无分部数据
LOGI
| Retail Gaming | $482.7M | 34% |
| Retail Keyboards Desktops | $254.6M | 18% |
| Retail Pointing Devices | $241.2M | 17% |
| Retail Video Collaboration | $193.3M | 14% |
| Retail Tablet And Other Accessories | $93.6M | 7% |
| Retail Webcams | $82.3M | 6% |
| Retail Headsets | $45.9M | 3% |
| Other Retail Products | $28.0M | 2% |
